Life Sciences Corporate Venture Investing: Where’s The Heartbeat And How’s The Patient?
Posted 11/02/05 at 1:55 pm
A panel discussion led by Bruce W. Jenett of Heller Ehrman LLP on November 2, 2005 at Heller Ehrman premises starting at 6:15 PM. Panelists include:
- Dr. Brad Vale, Johnson & Johnson Development Corporation
- Eran Raber, Investment Manager, Agilent Capital
- Richard Fuentes, Corporate Venture Capital, Dow Chemical Company
- Jim Adair, Vice President, Business development, Genentech.
